Diseases, Conditions, Syndromes

Late mortality down for blood or marrow transplant recipients

(HealthDay)—Allogeneic blood or marrow transplantation (BMT) recipients have experienced a reduction in late mortality over time, according to a study published online Sept. 9 in JAMA Oncology.


Sanofi buys US biotech firm in acquisition spree

French pharmaceutical giant Sanofi announced on Wednesday its second acquisition of a US firm in as many months, buying transplant drug company Kadmon for $1.9 billion (1.6 billion euros).